With her business growing rapidly, the founder of a biopharma company knew she needed guidance on her personal finances. She wanted to better understand the complex ownership structure of her assets and how that affected her personal wealth.
Careful guidance from a wealth advisor soon set her on the right course.
First, they looked together at the makeup of her equity holdings—including restricted stock, non-qualified stock options, incentive stock options and founder shares—and reviewed the tax implications associated with each form of ownership.
The wealth advisor then walked the founder through a number of strategies to quantify the benefits and risks of exercising her options or holding them.
With new insight into her wealth, she could see her full portfolio on one page. With that clear picture, she created a strategic wealth management plan.
Selling? Not so fast
With the guidance of her wealth advisor, the founder learned the implications of selling versus holding her restricted stock, and of exercising her options versus not exercising them.
She had been thinking of selling her qualified small business stock (QSBS) to help her daughter buy real estate. But after consulting with her wealth advisor, they recognized that selling these shares before meeting the five-year holding requirement would deny her a significant benefit in capital gains tax. Holding QSBS for the full five years would qualify for a 100% exclusion from capital gains tax, up to the greater of 10 times her basis in the stock, or $10 million—a significant realization.
Smart moves with trusts
The founder also wanted to know how to provide for the future of her daughter, her two sons, and her grandchildren. With the help of her wealth advisor, she learned exactly what assets she held across her entire portfolio, and in what quantities, so she could explain her portfolio to her children. She then worked with her attorney to update her will to reflect her updated financial picture.
Working with the advisor also revealed the benefits of setting up a revocable trust, including keeping assets outside of public probate proceedings at the time of death. Doing so gave her a level of privacy, because most of her assets, including her company holdings, became titled in the name of the revocable trust.
With her wealth expected to grow with a future sale or acquisition, she also considered an irrevocable trust.
Gifting appreciable assets to a trust, she learned, would remove these assets from her taxable estate. An irrevocable trust would also help her transfer wealth to her family with more tax efficiency: an exemption from generation-skipping tax would protect the assets from estate taxation in her children’s estates.
New wealth means new thinking
By taking the initiative to find valuable guidance, the biopharma founder saw her financial assets in an entirely new light—a perspective she shared with her children. Her discoveries with her wealth advisor helped her make more effective financial decisions. She also created a better approach to transferring wealth as she anticipated that the value of her company would increase even further in the future.
All case studies are shown for illustrative purposes only and should not be relied upon as advice or interpreted as a recommendation.
This material is intended to help you understand the financial consequences of the concepts and strategies discussed here in very general terms. The strategies discussed often involve complex tax and legal issues. Your own attorney and other tax advisors can help you consider whether the ideas illustrated here are appropriate for your individual circumstances. JPMorgan Chase & Co. does not practice law, and does not give tax, accounting or legal advice. We are available to consult with you and your legal and tax advisors as you move forward with your planning.
The views and strategies discussed here may not be suitable to all investors. This information is provided for informational purposes and is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Past performance is not indicative of future returns.
Lines of credit are extended at the discretion of J.P. Morgan, and J.P. Morgan has no commitment to extend a line of credit or make loans available under the line of credit. Any extension of credit is subject to credit approval by the lender in accordance with the terms contained in definitive loan documents.
Investors should be cautious when holding a highly concentrated stock position, which is generally defined as any individual holding that constitutes more than 30% of overall investment holdings. Tax consequences, including the avoidance of capital gains through selling, do not eliminate the risks of overexposure to a particular company or business sector.
“J.P. Morgan Private Bank” is a marketing name for private banking business conducted by JPMorgan Chase & Co. and its subsidiaries worldwide. Bank products and services, including certain discretionary investment management products and services, are offered by JPMorgan Chase Bank, N.A. and its affiliates. Securities are offered by J.P. Morgan Securities LLC, member FINRA and SIPC.
© 2017 JPMorgan Chase & Co. All rights reserved.